ArticleCancers2021

Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2- Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2- Breast Cancer.

Sven Roßwag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.